Archangel Investors Ltd portfolio company Blackford Analysis has been sold to global life science company Bayer Pharma.
Artificial intelligence-led medical imaging firm Blackford Analysis has been acquired by global life sciences group Bayer.
Spun out from the University of Edinburgh in 2010 and still headquartered in the city, Blackford has a presence in the UK and US, focused on providing healthcare providers with tailored tools and services.
Following the transaction, it will continue to operate as an independent organisation on an arm’s-length basis, remaining headquartered in Scotland with no changes to the management or staff.
The company will remain accountable to advance its technology, partnerships and clinical application portfolio, while benefiting from the infrastructure and reach of Bayer as a global pharmaceutical company.
Read more HERE.
